A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/10/2011	US20110275574 Method of inhibiting proliferation of hepatic stellate cells
11/10/2011	US20110275572 Nanocomposite Hyaluronic Acid-Clay Based Hydrogels
11/10/2011	US20110275571 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275565 Biocompatible polysaccharide-based hydrogels
11/10/2011	US20110275561 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
11/10/2011	US20110275558 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110275072 Egfr mutations
11/10/2011	US20110274778 Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
11/10/2011	US20110274775 Extracts of southernwood and topical uses thereof
11/10/2011	US20110274773 Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same
11/10/2011	US20110274771 Prenatal Syptomatic Kit
11/10/2011	US20110274770 Antiseptic compositions and methods
11/10/2011	US20110274762 Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274759 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/10/2011	US20110274758 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/10/2011	US20110274757 Nucleic acid delivery vehicle and uses thereof
11/10/2011	US20110274755 Supportive treatment of liver disease
11/10/2011	US20110274754 Oral tablet compositions of dexlansoprazole
11/10/2011	US20110274753 Dual release oral tablet compositions of dexlansoprazole
11/10/2011	US20110274752 Modified release pharmaceutical compositions of dexlansoprazole
11/10/2011	US20110274751 Trimetazidine formulation with different release profiles
11/10/2011	US20110274750 Enteric formulation of duloxetine and its core and prepration method
11/10/2011	US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
11/10/2011	US20110274748 CAI-Based Systems and Methods for the Localized Treatment of Ocular and Other Diseases
11/10/2011	US20110274746 Therapeutic Liposomes and Methods For Producing and Using the Same
11/10/2011	US20110274745 Instillation of liposomal formulation of sirna and antisense oligonucleotides
11/10/2011	US20110274743 Medicament for the Treatment of Pain and Inflammation
11/10/2011	US20110274742 Cartilage Repair Systems and Applications Utilizing A Glycosaminoglycan Mimic
11/10/2011	US20110274740 Methods of reducing symptoms in subjects using single dosage forms with tapering release rates
11/10/2011	US20110274739 Methods for governing tissue growth
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274733 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/10/2011	US20110274732 Medical device loaded with formulation for targeted delivery of biologically active material/s and method of manufacture thereof
11/10/2011	US20110274726 Chitosan foam medical devices and methods
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274724 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
11/10/2011	US20110274721 Hiv vaccines based on env of multiple clades of hiv
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274716 Compositions containing fucoxanthin extract
11/10/2011	US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/10/2011	US20110274703 Detection and treatment of non-dermal fibrosis
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274682 Methods for protease assisted protein delivery
11/10/2011	US20110274680 Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
11/10/2011	US20110274679 Compositions and Methods of SIRT Activation
11/10/2011	US20110274678 Beverage
11/10/2011	US20110274670 Mesenchymal stem cells which express human hepatic growth factor,manufacturing method thereof, and use thereof as therapeutic agent for liver diseases
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274656 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274654 Triazoles as inhibitors of fatty acid synthase
11/10/2011	US20110274651 Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
11/10/2011	US20110274648 Hepatitis C Virus Inhibitors
11/10/2011	US20110274646 Compounds and Combinations
11/10/2011	US20110274645 Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods
11/10/2011	US20110274644 Lens care compositions
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/10/2011	US20110274631 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
11/10/2011	US20110274629 Natural Polymer Blends for Use in Personal Care Products
11/10/2011	US20110274628 Nicotine-containing pharmaceutical compositions
11/10/2011	US20110274625 Liposomal Composition for Convection-Enhanced Delivery to the Central Nervous Centre
11/10/2011	US20110274621 Active Particles for Bio-Analytical Applications and Methods for Their Preparation
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	DE202011103553U1 Inhalationsdarreichungen in Form von Lösungen oder Trockenpulver für den Abbau von Schleimabsonderungen aus dem Atmungssystem Inhalationsdarreichungen in the form of solutions or dry powder for the degradation of mucus secretions from the respiratory system
11/10/2011	DE102010019416A1 Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum Orodispersible tablet comprising a triptan or an atypical antipsychotic
11/10/2011	CA2835313A1 Gfi1b modulation and uses thereof
11/10/2011	CA2812526A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/10/2011	CA2805267A1 Detection and treatment of fibrosis
11/10/2011	CA2800998A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
11/10/2011	CA2798923A1 Novel ophthalmic compositions
11/10/2011	CA2798116A1 Topical pharmaceutical composition comprising heparin
11/10/2011	CA2798082A1 Desazadesferrothiocin analogues as metal chelation agents
11/10/2011	CA2797050A1 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
11/10/2011	CA2795394A1 Treatment of autoimmune diseases
11/10/2011	CA2795105A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/10/2011	CA2795030A1 Novel low concentration meloxicam tablets
11/10/2011	CA2794607A1 Dosage regimen of diaryl sulfide derivatives
11/10/2011	CA2794309A1 Layered drug delivery device
11/10/2011	CA2793571A1 Propynylaminoindan transdermal compositions
11/10/2011	CA2776482A1 Compositions, gels and foams with rheology modulators and uses thereof
11/10/2011	CA2761074A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors
11/10/2011	CA2739751A1 Pharmaceutical compositions comprising hydromorphone and naloxone
11/09/2011	EP2385139A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385138A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385137A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385071A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2385054A1 Cefdinir acid double salt and its preparation
11/09/2011	EP2385049A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
11/09/2011	EP2385048A1 Hepatitis C virus inhibitors
11/09/2011	EP2385047A1 Piperidinyl-substituted isoquinolone derivatives
11/09/2011	EP2385044A1 Orodispersible tablet and process for preparing the same
11/09/2011	EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385038A1 Dimeric IAP inhibitors
11/09/2011	EP2385036A1 N-acyl anthranilic acid derivative or salt thereof

1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 7860